Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating a Novel Onco-genetic BRCA Testing Counselling Model Among Patients With Ovarian Cancer - ENGAGE Study

NCT02406235 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02406235
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02406235 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating a Novel Onco-genetic BRCA Testing Counselling Model Among Patients With Ovarian Cancer - ENGAGE Study
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
April 21, 2015
Completion date
September 30, 2016
Enrollment
710 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

epithelial ovarian/fallopian tube/primary peritoneal cancer